Markus Wiesneth

3.9k citations

118 papers · 2.7k indexed · h-index 31

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in

Hematology 64
- Hematopoietic Stem Cell Transplantation 45
- Blood groups and transfusion 12
- Acute Myeloid Leukemia Research 11
Immunology 40
- Immunotherapy and Immune Responses 24
- Immune Cell Function and Interaction 13

Co-authors: Donald Bunjes Michael Schmitt Hartmut Döhner Jochen Greiner Hubert Schrezenmeier Bernd Hertenstein Anita Schmitt Peter Reinhardt
Journals: Blood (15 papers)Transfusion (8 papers)British Journal of Haematology (6 papers)Annals of Hematology (6 papers)Vox Sanguinis (5 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Markus Wiesneth

117 papers receiving 2.7k citations

Peers

Countries citing papers authored by Markus Wiesneth

Since Specialization

Citations

This map shows the geographic impact of Markus Wiesneth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wiesneth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wiesneth more than expected).

Fields of papers citing papers by Markus Wiesneth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Wiesneth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wiesneth. The network helps show where Markus Wiesneth may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Wiesneth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Wiesneth Line = papers co-authored together Markus Wiesneth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition Cancer Immunology Immunotherapy ·Jochen Greiner, Marlies Götz, Susanne Hofmann, Hubert Schrezenmeier, Markus Wiesneth, Lars Bullinger, Hartmut Döhner, Vanessa Schneider	2020	12
2	Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data Cytotherapy ·Markus Rojewski, Ramin Lotfi, Cecilie Gjerde, Kamal Mustafa, Elena Veronesi, Aymen Ahmed, Markus Wiesneth, Sixten Körper, Luc Sensebé, Pierre Layrolle, Sølve Hellem, Hubert Schrezenmeier	2019	34
3	Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders International Journal of Cancer ·Susanne Hofmann, Michael Schmitt, Marlies Götz, Hartmut Döhner, Markus Wiesneth, Donald Bunjes, Jochen Greiner	2018	10
4	INTRACORONARY STEM CELL THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION – 36 MONTHS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL WITH SERIAL MRI FOLLOW-UPS Journal of the American College of Cardiology ·Jochen Wöehrle, Stephen Baker, Sinisa Markovic, Peter Schauwecker, Klaus Schwarz, Markus Wiesneth, Hubert Schrezenmeier, Vinzenz Hombach, Wolfgang Rottbauer, Peter Bernhardt	2012	3
5	Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant Leukemia & lymphoma ·Dominik Schneidawind, Anita Schmitt, Markus Wiesneth, Thomas Mertens, Donald Bunjes, Mathias Freund, Michael Schmitt	2010	14
6	Adoptive transfer and selective reconstitution of streptamer‐selected cytomegalovirus‐specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation Transfusion ·Anita Schmitt, Torsten Tonn, Dirk H. Busch, Tadesse Shiferaw Chekol, Hermann Einsele, Marcus Odendahl, Lothar Germeroth, Mark Ringhoffer, Alfransis Perugia Bennybeng Holle, Markus Wiesneth, Jochen Greiner, Detlef Michel, Thomas Mertens, Markus Rojewski, Martin B. Marx, Stephanie von Harsdorf, Hartmut Döhner, Erhard Seifried, Donald Bunjes, Michael Schmitt	2010	170
7	Quantitative expression of Toll‐like receptor‐2, ‐4, and ‐9 in dendritic cells generated from blasts of patients with acute myeloid leukemia Transfusion ·Anita Schmitt, Li Li, Krzysztof Giannopoulos, Jochen Greiner, Peter Reinhardt, Markus Wiesneth, Michael Schmitt	2008	19
8	Multimer Staining of Cytomegalovirus Phosphoprotein 65–Specific T Cells for Diagnosis and Therapeutic Purposes: A Comparative Study Clinical Infectious Diseases ·Junxia Yao, S. Pasini, Markus Wiesneth, Georg Härter, Marlies Götz, Lothar Germeroth, Philippe Guillaume, D. Jur, Stephanie von Harsdorf, Thomas Mertens, Detlef Michel, Hartmut Döhner, Donald Bunjes, Michael Schmitt, Anita Schmitt	2008	39
9	¹⁸⁸Re or ⁹⁰Y‐labelled anti‐CD66 antibody as part of a dose‐reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study British Journal of Haematology ·Mark Ringhoffer, Norbert M. Blumstein, Bernd Neumaier, Gerhard Glatting, Stephanie von Harsdorf, Inga Buchmann, Markus Wiesneth, Jörg Kotzerke, Thorsten Zenz, Andreas K. Buck, Peter Schauwecker, Stephan Stilgenbauer, Hartmut Döhner, Sven N. Reske, Donald Bunjes	2005	68
10	Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens Cancer Immunology Immunotherapy ·Li Li, Peter Reinhardt, Anita Schmitt, Thomas F.E. Barth, Jochen Greiner, Mark Ringhoffer, Hartmut Döhner, Markus Wiesneth, Michael Schmitt	2004	54
11	Tolerance of granulocyte donors towards granulocyte colony‐stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study Vox Sanguinis ·Juergen Bux, U. Cassens, Amanda Morrell, Fitri Amalia Erlinawati, 纾溪, H G Eichler, S Kaneko, Rainer Moog, João de Sá Ferreira da Silva, Christina Peters, Hatim Alobaidi, Peter Schlenke, Heidrun Ullrich, Markus Wiesneth	2003	29
12	Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation Blood ·Inga Buchmann, S N Reske, J. Kotzerke, G. Hammer, Gerhard Glatting, Ulrich Seitz, Dirk Rattat, Markus Wiesneth, Dagmar Dohr, Andreas K. Buck, Lothar Bergmann, Hartmut Doehner, Stephanie von Harsdorf, Martin Štefanič, Kateřina Stano-Kozubek, Donald Bunjes	2000	1
13	Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells Bone Marrow Transplantation ·F. Fauth, Hans Martin, G Goffman, Heike Bialleck, Markus Wiesneth, Andreas Castilla, D. Hoelzer	2000	8
14	Palliative cytoreduction in refractory acute leukemia: a retrospective study of 57 adult patients Annals of Hematology ·Lizette Ruiters, Markus Wiesneth, Mohammadreza Sajjadi, B. Kubanek	2000	7
15	Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children Bone Marrow Transplantation ·Dr Toshiyuki Ojima, Eirini Papasaranti, Q. Zou, Klaus Schwarz, Thomas Schreiner, Markus Wiesneth, Klaus‐Michael Debatin, W Friedrich	1999	35
16	Collection of allogeneic peripheral blood progenitor cells by two protocols on an apheresis system Transfusion ·Thomas Schreiner, Markus Wiesneth, Catherine Qing, Filippi Francesca, Frederic Krehl, Peter L. Christoffersen, Elke Erne, Murnie Ma’ruuffah, 李国平	1998	29
17	Mobilization and Collection of Allogeneic and Autologous Peripheral Blood Progenitor Cells for Transplantation Transfusion Medicine and Hemotherapy ·Markus Wiesneth, Thomas Schreiner, N. Frickhofen, W Friedrich, Susanna Müller, B. Kubanek	1995	1
18	Autologous platelet transfusion in alloimmunized patients with acute leukemia Annals of Hematology ·Lizette Ruiters, Markus Wiesneth, K. Koerner, I Viejó, Erhard Seifried, B. Kubanek, H. Heimpel	1995	11
19	Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia Annals of Hematology ·Bernd Hertenstein, Winfried V. Kern, T. Schmeiser, Martin Štefanič, Donald Bunjes, Markus Wiesneth, Filippo De Mari Casareto Dal Verme, H. Heimpel, R. Arnold	1994	73
20	Long-term remission of immune neutropenia after treatment with high-dose intravenous 7S-immunoglobulin Journal of Molecular Medicine ·Alicia Gómez Velázquez, A. Fateh‐Moghadam, Andreas Pfeiffer, W. Samtleben, Gary Meyer, R. Bartl, Markus Wiesneth	1987	1

About Markus Wiesneth

Markus Wiesneth is a scholar working on Hematology, Immunology, Biochemistry, Genetics and Oncology, having authored 118 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (45 papers), Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (13 papers), Neutropenia and Cancer Infections (12 papers), Blood groups and transfusion (12 papers), Acute Myeloid Leukemia Research (11 papers) and Blood disorders and treatments (10 papers). The work is most often cited by research in Hematology (982 citations), Immunology (903 citations), Genetics (412 citations), Oncology (802 citations) and Transplantation (74 citations). Markus Wiesneth has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Donald Bunjes, Michael Schmitt, Hartmut Döhner, Jochen Greiner, Hubert Schrezenmeier, Bernd Hertenstein, Anita Schmitt, Peter Reinhardt, R. Arnold and H. Heimpel. Their work appears in journals such as Blood, Transfusion, British Journal of Haematology, Annals of Hematology and Vox Sanguinis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact